Eurobio Scientific Société anonyme (EPA:ALERS)
24.55
+0.30 (1.24%)
At close: Dec 5, 2025
EPA:ALERS Revenue
Eurobio Scientific Société anonyme had revenue of 80.80M EUR in the half year ending June 30, 2025, with 36.09% growth. This brings the company's revenue in the last twelve months to 162.47M, up 12.40% year-over-year. In the year 2024, Eurobio Scientific Société anonyme had annual revenue of 154.95M with 18.60% growth.
Revenue (ttm)
162.47M
Revenue Growth
+12.40%
P/S Ratio
1.52
Revenue / Employee
427.56K
Employees
326
Market Cap
247.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 154.95M | 24.30M | 18.60% |
| Dec 31, 2023 | 130.65M | -22.25M | -14.55% |
| Dec 31, 2022 | 152.90M | -32.42M | -17.49% |
| Dec 31, 2021 | 185.32M | -3.87M | -2.04% |
| Dec 31, 2020 | 189.19M | 129.71M | 218.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.93B |
| Sartorius Stedim Biotech | 2.95B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |